Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE)

$20.91 +1.10 (+5.55%)
As of Apr 21, 2026 03:59 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001826457
Market Cap 1.55 Bn
P/E -40.54
P/S 12.53
Div. Yield 0.00
ROIC (Qtr) -0.22
Revenue Growth (1y) (Qtr) -95.41
Add ratio to table...

About

Agreement Breakdown of Revenue (2024)

Equity Components Breakdown of Revenue (2024)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.34 Bn 28.15 9.28 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.06 Bn 17.30 5.44 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 41.92 Bn 152.39 13.31 -
4 RVMD Revolution Medicines, Inc. 28.36 Bn -25.11 34,170.56 -
5 ZLAB Zai Lab Ltd 25.77 Bn -147.06 106.30 0.20 Bn
6 MESO Mesoblast Ltd 24.32 Bn -190.54 1,414.27 0.12 Bn
7 MRNA Moderna, Inc. 21.25 Bn -7.52 10.93 0.59 Bn
8 RPRX Royalty Pharma plc 20.83 Bn 27.08 8.76 8.95 Bn